Epilepsy surgery in PCDH 19 related developmental and epileptic encephalopathy: A case report.
Epilepsy Behav Rep
; 19: 100560, 2022.
Article
in En
| MEDLINE
| ID: mdl-35856042
We report a female child with PCDH19 related developmental and epileptic encephalopathy with drug-resistant seizures, cognitive and language impairment, autism spectrum disorder and sleep dysfunction. Her seizures, which started at 10 months of age, were resistant to multiple anti-seizure medications. Developmental stagnation followed by regression occurred after the onset of recurrent seizures. Her ictal EEGS suggested left temporal lobe origin for her recorded seizures. MRI upon expert re-review showed a subtle abnormality in the left temporal lobe. In view of the severe nature and frequency of her seizures, a left temporal lobectomy was undertaken at the age of 2 years and 3 months. Though her seizure outcome was Engel class 3, her seizure frequency and severity were significantly reduced. She has been seizure-free for 10 months at her last outpatient assessment when she was 4 years and 8 months of age (2 years and 5 months after epilepsy surgery). However she recently had an admission for COVID19 infection, with a breakthrough cluster of seizures. Her developmental trajectory changed, though she is making good progress with her cognitive and language skills.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Epilepsy Behav Rep
Year:
2022
Type:
Article
Affiliation country:
Australia